Hospital Profile
Name | Scotland Memorial Hospital |
---|
Type | Acute Care Hospital |
---|
Location | 500 Lauchwood Dr, Laurinburg, North Carolina |
---|
Ownership | Voluntary non-profit - Private |
---|
Emergency Services | Yes |
---|
Medicare ID (CCN) | 340008 |
Patients' Experience Survey:
Overall Rating of the Hospital:
Willingness to Recommend Hospital:
Yes Patients who reported YES, they would definitely recommend the hospital
Probably Patients who reported YES, they would probably recommend the hospital
No Patients who reported NO, they would probably not or definitely not recommend the hospital
Cleanliness of Hospital Environment:
Always Patients who reported that their room and bathroom were "Always" clean
Usually Patients who reported that their room and bathroom were "Usually" clean
Sometimes or Never Patients who reported that their room and bathroom were "Sometimes" or "Never" clean
Quietness of Hospital Environment:
Always Patients who reported that the area around their room was "Always" quiet at night
Usually Patients who reported that the area around their room was "Usually" quiet at night
Sometimes or Never Patients who reported that the area around their room was "Sometimes" or "Never" quiet at night
Always Patients who reported that their nurses "Always" communicated well
Usually Patients who reported that their nurses "Usually" communicated well
Sometimes or Never Patients who reported that their nurses "Sometimes" or "Never" communicated well
Always Patients who reported that their doctors "Always" communicated well
Usually Patients who reported that their doctors "Usually" communicated well
Sometimes or Never Patients who reported that their doctors "Sometimes" or "Never" communicated well
Responsiveness of Hospital Staff:
Always Patients who reported that they "Always" received help as soon as they wanted
Usually Patients who reported that they "Usually" received help as soon as they wanted
Sometimes or Never Patients who reported that they "Sometimes" or "Never" received help as soon as they wanted
Communication about Medicines:
Always Patients who reported that staff "Always" explained about medicines before giving it to them
Usually Patients who reported that staff "Usually" explained about medicines before giving it to them
Sometimes or Never Patients who reported that staff "Sometimes" or "Never" explained about medicines before giving it to them
Yes Patients who reported that YES, they were given information about what to do during their recovery at home
No Patients who reported that NO, they were not given information about what to do during their recovery at home
Always Patients who "Strongly Agree" they understood their care when they left the hospital
Usually Patients who “Agree” they understood their care when they left the hospital
Sometimes or Never Patients who “Disagree” or “Strongly Disagree” they understood their care when they left the hospital
NPI Associated with the Hospital:
Unlike individual providers, Hospitals may have multiple NPI numbers for example, there can be a separate NPI for each unit within the hospital. We have found possible NPI number/s associated with Scotland Memorial Hospital from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.
NPI Number | 1457345597 |
Organization Name | SCOTLAND MEMORIAL HOSPITAL INC |
Doing Business As | SCOTLAND MEMORIAL HOSPITAL, INC. |
Address | 500 Lauchwood Dr, Laurinburg, NC 28352 |
Hospital Type | General Acute Care Hospital |
Phone Number | 910-291-7000 |
News Archive
Shire, Janssen enter development and marketing agreement for Resolor
Shire plc, the global specialty biopharmaceutical company, announced today that it has acquired the rights to develop and market Resolor (prucalopride) in the United States (US) in an agreement with Janssen Pharmaceutica N.V.
City funding reaches needle-exchange programs in Washington, D.C.
Funding for needle-exchange programs in Washington, D.C., is beginning to reach groups that run the programs eight months after Congress lifted a ban of city funding for needle-exchange programs, but it is unclear how effective the increased funding will be at reducing the spread of HIV in the district, the AP/Washington Times reports (Westley, AP/Washington Times, 8/24).
Autism Associations shows CDC and FDA to be negligent
National Autism Association announced Tuesday that the Centers for Disease Control (CDC), Food and Drug Administration (FDA) and some pharmaceutical companies have become a target for investigation.
Athersys second-quarter revenues increase to $1.9 million
Athersys, Inc. today announced its financial results for the quarter ended June 30, 2010.
Charles River Laboratories International reports 1.4% decline in first-quarter 2010 net sales
Charles River Laboratories International, Inc. today reported its results for the first quarter of 2010. For the quarter, net sales were $297.3 million, a decline of 1.4% from $301.5 million in the first quarter of 2009. The decrease was net of a foreign currency translation benefit of 3.4%. Higher sales for the Research Models and Services (RMS) segment were offset by lower sales for the Preclinical Services (PCS) segment.
Read more Medical News
› Verified 6 days ago
Structural Quality Measures:
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Shire, Janssen enter development and marketing agreement for Resolor
Shire plc, the global specialty biopharmaceutical company, announced today that it has acquired the rights to develop and market Resolor (prucalopride) in the United States (US) in an agreement with Janssen Pharmaceutica N.V.
City funding reaches needle-exchange programs in Washington, D.C.
Funding for needle-exchange programs in Washington, D.C., is beginning to reach groups that run the programs eight months after Congress lifted a ban of city funding for needle-exchange programs, but it is unclear how effective the increased funding will be at reducing the spread of HIV in the district, the AP/Washington Times reports (Westley, AP/Washington Times, 8/24).
Autism Associations shows CDC and FDA to be negligent
National Autism Association announced Tuesday that the Centers for Disease Control (CDC), Food and Drug Administration (FDA) and some pharmaceutical companies have become a target for investigation.
Athersys second-quarter revenues increase to $1.9 million
Athersys, Inc. today announced its financial results for the quarter ended June 30, 2010.
Charles River Laboratories International reports 1.4% decline in first-quarter 2010 net sales
Charles River Laboratories International, Inc. today reported its results for the first quarter of 2010. For the quarter, net sales were $297.3 million, a decline of 1.4% from $301.5 million in the first quarter of 2009. The decrease was net of a foreign currency translation benefit of 3.4%. Higher sales for the Research Models and Services (RMS) segment were offset by lower sales for the Preclinical Services (PCS) segment.
Read more News
› Verified 6 days ago